Camber launches generic Evista

PISCATAWAY, N.J. — Camber Pharmaceuticals announced the launch of raloxifene hydrochloride, USP tablets in 60-mg dosage strengths. The drug is the generic version of Evista tablets from Eli Lilly and Co. Raloxifene will be available in 30- and 100-count bottles. 

 

“Raloxifene is an important product addition in Camber’s portfolio, one of many we have planned in the coming months” said Kon Ostaficiuk, president of Camber. “Our continued growth as a leading generic supplier is a testament to our strong API manufacturing and the integrity of our supply chain.”